Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Eur Rev Med Pharmacol Sci ; 24(19): 10293-10300, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-890965

ABSTRACT

Acute SARS-CoV-2 respiratory disease is an infectious respiratory disease caused by the virus SARS-CoV-2 belonging to the coronaviridae family. A pandemic is still present as of May 2020. In addition to causing pneumonia, SARS-CoV-2 may induce a direct damage to the heart, causing myocarditis, with significant impairment of cardiac contractility, and/or pericarditis. Elderly patients and those with cardiovascular risk factors, such as hypertension and diabetes mellitus, are at increased risk of heart complications from COVID-19. In this review, we focused on the correlation between COVID-19 infection and the high sensitivity troponin T and I, and their significance in the development of myocarditis. Data emerging from the studies so far conducted indicate that a high value of high-sensitivity troponin represents a negative prognostic indicator when associated with heart damage on an infectious-inflammatory basis (i.e. myopericarditis). We should identify a safe and clear diagnostic algorithm, possibly combining patient clinical history, troponin levels and cardiac ultrasound findings that could help us in the prediction of myopericarditis.


Subject(s)
COVID-19/diagnosis , Myocarditis/diagnosis , Troponin I/blood , Troponin T/blood , COVID-19/blood , COVID-19/complications , Humans , Myocarditis/blood , Myocarditis/complications , Pandemics , Prognosis , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL